 Home > Active Ingredient News > Antitumor Therapy > Prostate: Does metformin have an effect on mortality in Asian prostate cancer with diabetes who undergo androgen deprivation therapy?

Prostate: Does metformin have an effect on mortality in Asian prostate cancer with diabetes who undergo androgen deprivation therapy?

 Last Update: 2022-10-12
 Source: Internet
 Author: User

Tags

2 4 application

2 7 8 decimal

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Globally, prostate cancer (PCa) was the second most common cancer and the fifth leading cause

Recently, researchers from China published an article in Prostate investigating the relationship between

The researchers reviewed adult patients treated with ADT with diabetes who were treated with ADT in Hong Kong public hospitals between December 1999 and March 2021 and followed up until September

The study's analysed cohort included 1971 patients (1284 metformin users and 687 non-users; The mean age was 76.

Cumulative freedom of prostate-related mortality

In summary, simultaneous use of metformin with ADT is associated

Original Source:

Yan Hiu Athena Lee ， Jeremy Man Ho Hui ， Jeffrey Shi Kai Chan et al.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Bulk Peptides Kisspeptin 10 (human) /Kisspeptin 10/ Kisspeptin-10 Acetate CAS 374675-21-5

CAS No.: 374675-21-5

Pharmacy Grade

$10-13/UNIT FOB

Cediranib

CAS No.: 288383-20-0

$22/KG EXW

Upadacitinib hemihydrate API

CAS No.: 2050057-56-0

Pharmacy Grade

$35-45/G FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

80 20 company(94)

united states logo(227)

ups united states(221)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.